Title (BMT CTN Protocol 0901) A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
Contact DC
Principal Investigator Maureen Ross, MD
Study Number 218612
Phase3
Summary The study is designed as a Phase III, multicenter trial comparing outcomes after allogenetic hematopoietic stem cell transplantation (HCT) for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) between patients receiving myeloablative conditioning (NAC) versus reduced intensity conditioning (RIC) regimens.
Eligibility See Clinicaltrials.gov listing